Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Thematic (Sector/Industry)

<ul><li>Biopharma lagged as Trump’s pending pharma tariffs loom.</li><li>The 90-day pause in reciprocal tariffs was a short-lived reprieve for biopharma, as Trump later clarified pharma tariffs were not part of the pause.</li><li>After a second unvaccinated child died from measles (three deaths total), RFK Jr. endorsed the vaccine as the most effective way of prevention. </li></ul>

Biopharma lagged as Trump’s pending pharma tariffs loom.The 90-day pause in reciprocal tariffs was a short-lived reprieve for biopharma, as Trump later clarified pharma tariffs were not part of the pause.After a second unvaccinated child died from measles (three deaths total), RFK Jr. endorsed the vaccine as the most effective way of prevention. 

Biopharma Week in Review : Pharma Tariffs Overhang; Worrying Vaccine Comments from RFK Jr.

Equity Bottom-Up

Global Water Resources  / Equity Bottom-Up

<ul><li>The WTR Sustainable Index was up 1.7% W/W versus the S&amp;P 500 Index (up 1.7%), the Russell 2000 Index (up 1.4%) and the Nasdaq Index (up 1.6%).</li><li>Energy Technology (13.7% of the index) was up 1.9%, while Industrial Climate and Ag Technology (47.6% of the index) was up 2.6%, ClimateTech Mining was up 1.4%, and Advanced Transportation Solutions (20.9% of the index) was up 1.6%.</li><li>Top 10 Performers: WML, WWR, LTBR, SMR, MGPHF, BE, PSIX, GTEC, LOOP, WPRT</li></ul>

The WTR Sustainable Index was up 1.7% W/W versus the S&amp;P 500 Index (up 1.7%), the Russell 2000 Index (up 1.4%) and the Nasdaq Index (up 1.6%).Energy Technology (13.7% of the index) was up 1.9%, while Industrial Climate and Ag Technology (47.6% of the index) was up 2.6%, ClimateTech Mining was up 1.4%, and Advanced Transportation Solutions (20.9% of the index) was up 1.6%.Top 10 Performers: WML, WWR, LTBR, SMR, MGPHF, BE, PSIX, GTEC, LOOP, WPRT

Sustainable Investing Surveyor Focus on Global Water Resources, Inc. (GWRS)

<ul><li>The WTR Sustainable Index was up 3.2% W/W versus the S&amp;P 500 Index (up 2.9%), the Russell 2000 Index (up 4.0%) and the Nasdaq Index (up 2.8%).</li><li>Energy Technology (13.7% of the index) was up 0.9%, while Industrial Climate and Ag Technology (47.2% of the index) was up 4.5%, ClimateTech Mining was up 2.2%, and Advanced Transportation Solutions (21.3% of index) was up 2.7%.</li><li>Top 10 Performers: AZRE, DCFC, FGPHF, IDEX, TMC, IONR, GWTI, LITM, CLIR, EOSE</li></ul>

The WTR Sustainable Index was up 3.2% W/W versus the S&amp;P 500 Index (up 2.9%), the Russell 2000 Index (up 4.0%) and the Nasdaq Index (up 2.8%).Energy Technology (13.7% of the index) was up 0.9%, while Industrial Climate and Ag Technology (47.2% of the index) was up 4.5%, ClimateTech Mining was up 2.2%, and Advanced Transportation Solutions (21.3% of index) was up 2.7%.Top 10 Performers: AZRE, DCFC, FGPHF, IDEX, TMC, IONR, GWTI, LITM, CLIR, EOSE

Sustainable Investing Surveyor - Focus on Montauk Renewables, Inc. (MNTK)

Clean Energy Technologies  / Equity Bottom-Up

<ul><li>The WTR Sustainable Index was down 3.1% W/W versus the S&amp;P 500 Index (down 1.9%), the Russell 2000 Index (down 3.5%), and the Nasdaq Index (down 2.2%).</li><li>Energy Technology (14.0% of the index) was down 3.8%, while Industrial Climate and Ag Technology (46.6% of the index) was down 1.8%, ClimateTech Mining was down 2.9%, and Advanced Transportation Solutions (21.4% of index) was down 5.3%.</li><li>Top 10 Performers: SPI, BNRG, AZRE, ARVL, TGEN, ARBE, EGT, GP, GCEI, PSI</li></ul>

The WTR Sustainable Index was down 3.1% W/W versus the S&amp;P 500 Index (down 1.9%), the Russell 2000 Index (down 3.5%), and the Nasdaq Index (down 2.2%).Energy Technology (14.0% of the index) was down 3.8%, while Industrial Climate and Ag Technology (46.6% of the index) was down 1.8%, ClimateTech Mining was down 2.9%, and Advanced Transportation Solutions (21.4% of index) was down 5.3%.Top 10 Performers: SPI, BNRG, AZRE, ARVL, TGEN, ARBE, EGT, GP, GCEI, PSI

Sustainable Investing Surveyor - Focus on Clean Energy Technologies, Inc.

<ul><li>For psychedelics, 2024 could be defined by the disappointing outcome of the FDA’s August review decision on Lykos Therapeutics’ (formerly MAPS) NDA for its MDMA-AT candidate for PTSD.</li><li>The FDA’s decision flew in the face of the anticipatory excitement following the NDA submission and award of breakthrough therapy designation earlier in the year following impressive results from Lykos’ two- part Phase 3 trial.</li><li>However, as disappointing as it is, particularly for the many millions of PTSD sufferers and Lykos, which subsequently reduced its workforce by 75%, in the grand scheme of things, this is only a temporary setback.</li></ul>

For psychedelics, 2024 could be defined by the disappointing outcome of the FDA’s August review decision on Lykos Therapeutics’ (formerly MAPS) NDA for its MDMA-AT candidate for PTSD.The FDA’s decision flew in the face of the anticipatory excitement following the NDA submission and award of breakthrough therapy designation earlier in the year following impressive results from Lykos’ two- part Phase 3 trial.However, as disappointing as it is, particularly for the many millions of PTSD sufferers and Lykos, which subsequently reduced its workforce by 75%, in the grand scheme of things, this is only a temporary setback.

Shroom Shmooz Psychedelics: Trends to Watch Going into 2025

United States

SPDR S&P 500 ETF Trust is an exchange-traded fund incorporated in the USA. The ETF tracks the S&P 500 Index. The Trust consists of a portfolio representing all 500 stocks in the S&P 500 Index. It holds predominantly large-cap U.S. stocks. This ETF is structured as a Unit Investment Trust and pays dividends on a quarterly basis. The holdings are weighted by market capitalization.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

SPDR S&P 500 (SPY US)

Biopharma Week in Review : Pharma Tariffs Overhang; Worrying Vaccine Comments from RFK Jr.

The 90-day pause in reciprocal tariffs was a short-lived reprieve for biopharma, as Trump later clarified pharma tariffs were not part of the pa

Water Tower Research

Sustainable Investing Surveyor Focus on Global Water Resources, Inc. (GWRS)

The WTR Sustainable Index was up 1.7% W/W versus the S&P 500 Index (up 1.7%), the Russell 2000 Index (up 1.4%) and the Nasdaq Index (up 1.6%).

Water Tower Research

Sustainable Investing Surveyor - Focus on Montauk Renewables, Inc. (MNTK)

The WTR Sustainable Index was up 3.2% W/W versus the S&P 500 Index (up 2.9%), the Russell 2000 Index (up 4.0%) and the Nasdaq Index (up 2.8%).

Water Tower Research

Sustainable Investing Surveyor - Focus on Clean Energy Technologies, Inc.

The WTR Sustainable Index was down 3.1% W/W versus the S&P 500 Index (down 1.9%), the Russell 2000 Index (down 3.5%), and the Nasdaq Index (down...

Water Tower Research

Shroom Shmooz Psychedelics: Trends to Watch Going into 2025

For psychedelics, 2024 could be defined by the disappointing outcome of the FDA’s August review decision on Lykos Therapeutics’ (formerly MAPS) NDA...

Water Tower Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)